HC Wainwright Maintains Ocular Therapeutix Price Target at $25
HC Wainwright & Co. maintained its $25.00/share price target for Ocular Therapeutix, per Benzinga (TradingView News).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.